|
End-of-day quote
Shenzhen S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 177.60 CNY | +8.21% |
|
+6.60% | +91.11% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 62,579 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 91.93% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 57,906 | 58,923 | 59,722 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 119.86% | 1.76% | 1.36% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 47.3x | 35.7x | 29.4x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.42x | 3.19x | 2.94x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.5x | 1.1x | 1.4x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.74x | 6.38x | 5.27x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 7.16x | 6.01x | 5.03x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 28.2x | 22.8x | 18.8x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 37.2x | 29.2x | 24.2x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -117x | 70.9x | 45x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -0.85% | 1.41% | 2.22% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.353 | 1.808 | 2.133 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.76% | 1.02% | 1.2% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.754 | 4.979 | 6.042 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 36% | 36.3% | 35.3% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,089 | 9,803 | 11,873 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,057 | 2,585 | 3,176 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,558 | 2,016 | 2,467 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,412 | 1,818 | 2,162 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -4,673 | -3,656 | -2,857 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 177.60 | 177.60 | 177.60 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 47.31x | 7.16x | 28.15x | 0.76% | 9.32B | |
| 32.41x | 11.77x | 23.88x | 0.61% | 1,015B | |
| 29.62x | 6.59x | 18.45x | 2.02% | 642B | |
| 33.52x | 7.76x | 16.03x | 2.62% | 463B | |
| 19.65x | 4.78x | 11.85x | 2.77% | 353B | |
| 19.69x | 5.14x | 12.76x | 3.13% | 265B | |
| 21.05x | 4.32x | 12.35x | 2.04% | 254B | |
| 24.13x | 6.36x | 11.33x | 2.64% | 206B | |
| 12.48x | 4.54x | 9.49x | 4.03% | 191B | |
| -44.28x | 6.46x | 25.23x | 2.25% | 182B | |
| Average | 19.56x | 6.49x | 16.95x | 2.29% | 357.95B | |
| Weighted average by Cap. | 23.65x | 7.63x | 17.65x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
